Clinical Trial Update: Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating non-contrast lung perfusion mapping as a new imaging approach in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Cystic Fibrosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING